| (-)Paliperidone;(+)Paliperidone | LC/MS/MS | 50-10000 pg/mL | Human EDTA Plasma | |
| Aliskiren | Cardiovascular | LC/MS/MS | 1-500 ng/mL | Human EDTA Plasma |
| Alvimopan;ADL 08-0011 | Gastrointesninal | LC/MS/MS | 100-20000 pg/mL; 0.5-100 ng/mL | Human EDTA Plasma |
| Atorvastatin lactones | Cardiovascular | LC/MS/MS | 10-10000 pg/mL, 10-5000 pg/mL, 50-50000 pg/mL | Human Plasma |
| Bivalirudin | Antithrombotic | LC/MS/MS | 5-5000 ng/mL | Human sodium citrate plasma |
| Bupivicaine | Pain | LC/MS/MS | 100-5000 ng/mL | Pig Plasma |
| Carboplatin | TBD | ICP/MS | 1-100 µg/mL | Human EDTA Plasma |
| Dienogest | TBD | LC/MS/MS | 1-160 ng/mL | Human EDTA Plasma |
| Dutasteride | Endocrinology | LC/MS/MS | 50-5000 pg/mL | Human EDTA Plasma |
| Epirubicin | Oncology | LC/MS/MS | 5-1000 ng/mL | Rabbit Plasma |
| Everolimus | oncology | LC/MS/MS | 100-100000 pg/mL | Human Whole Blood |
| Fluorouracil | Oncology | LC/MS/Ms | 10-5000 ng/mL | Stabilized Human EDTA Plasma |
| Granisetron | Gastrointestinal | LC/MS/MS | 20-15000 pg/mL | Human Plasma |
| Isotretinoin; 4-Oxo-Isotretinoin | LC/MS/MS | 1-800 ng/mL | Human EDTA plasma | |
| Lapatinib | TBD | LC/MS/MS | 100-10000 ng/mL | Human EDTA Plasma |
| Lercanidipine | Cardiovascular | LC/MS/MS | 25-10000 pg/mL | Human EDTA Plasma |
| Leuprolide | Oncology OR Endocrinology | LC/MS/MS | TBD | Human EDTA Plasma |
| Levomethadone; Dextromethadone | Miscellaneous | LC/MS/MS | 0.5-100 ng/mL | Human Lithium Heparinized Plasma |
| Methazolamide | LC/MS/MS | 100-100000 ng/mL | Human Whole Blood | |
| Methazolamide | LC/MS/MS | 5-10000 ng/mL | Human EDTA Plasma | |
| Mitoxantrone | TBD | LC/MS/MS | 0.5-100 ng/mL | Human EDTA Plasma |
| Mycophenolic Acid Glucuronide; Mycophenolic Acid Acyl Glucuronide; Mycophenolic Acid 7-o-beta Glucoside | Immunology | LC/MS/MS | 68-68000 ng/mL; 3.4-3400 ng/mL; 4-3400 ng/mL | Rat Plasma |
| Nitrofurantoin | TBD | LC/MS/MS | 1-1000 ng/mL | Human EDTA Plasma |
| Pegasys (Pegylated Interferon alpha 2a) | Respiratory | Elisa | 312.5-40000 pg/mL | Human Serum |
| Pentoxifylline; Metabolite I; Metabolite V | Hematologic Agent | LC/MS/MS | 1-500 ng/mL; 2-1000 ng/mL; 3-1500 ng/mL | Human EDTA Plasma |
| Phenylephrine free | Infectious Disease | LC/MS/MS | 10-2500 pg/mL | Human Plasma |
| Posaconazole | TBD | LC/MS/MS | 1-500 ng/mL | Human EDTA Plasma |
| Rasagiline | TBD | LC/MS/MS | 50-10000 pg/mL | Human EDTA Plasma |
| Rifampin | TBD | LC/MS/MS | 50-12500 ng/mL | Human Whole Blood |
| Riluzole | Central Nervous System Agents | LC/MS/MS | 0.5-500 ng/mL | Human EDTA Plasma |
| Rizatriptan; N-Desmethyl Rizatrptan | Pain | LC/MS/MS | 100-40000 pg/mL;10-4000 pg/mL | Human EDTA Plasma |
| Solifenacin | Genitourinary | LC/MS/MS | 100-20000 pg/mL | Human Plasma |
| Temozolomide | TBD | LC/MS/MS | 100-25000 ng/mL | Human EDTA Plasma |
| Testosterone;Dihydrotestosterone | Endocrinology | LC/MS/MS | 50-10000 pg/mL | Human Sodium Fluoride/Potassium Oxalate Plasma |
| Tinidazole | TBD | LC/MS/MS | 40-40000 ng/mL | Human EDTA Plasma |
| Trospium | Genitourinary | LC/MS/MS | 4-2000 pg/mL | Human EDTA Plasma |